Cargando…

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

BACKGROUND: Measures of general cognitive and adaptive ability in adults with Down syndrome (DS) used by previous studies vary substantially. This review summarises the different ability measures used previously, focusing on tests of intelligence quotient (IQ) and adaptive behaviour (AB), and where...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamburg, Sarah, Lowe, Bryony, Startin, Carla Marie, Padilla, Concepcion, Coppus, Antonia, Silverman, Wayne, Fortea, Juan, Zaman, Shahid, Head, Elizabeth, Handen, Benjamin L., Lott, Ira, Song, Weihong, Strydom, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716931/ https://www.ncbi.nlm.nih.gov/pubmed/31470792 http://dx.doi.org/10.1186/s11689-019-9279-8

Ejemplares similares

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)
por: Startin, Carla M., et al.
Publicado: (2016)

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome
por: Saini, Fedal, et al.
Publicado: (2023)

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2016)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls
por: Hamburg, Sarah, et al.
Publicado: (2021)

Aging and Down Syndrome
por: Head, Elizabeth, et al.
Publicado: (2012)

Health comorbidities and cognitive abilities across the lifespan in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2020)

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome
por: Hamburg, Sarah, et al.
Publicado: (2019)

The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer’s Disease in Down Syndrome
por: Pape, Sarah E., et al.
Publicado: (2021)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome
por: D’Souza, Hana, et al.
Publicado: (2020)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome
por: Firth, Nicholas C., et al.
Publicado: (2018)

The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease
por: Rujeedawa, Tanzil, et al.
Publicado: (2021)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years
por: Hithersay, Rosalyn, et al.
Publicado: (2018)

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
por: Baumer, Nicole T., et al.
Publicado: (2022)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
por: Startin, Carla M., et al.
Publicado: (2019)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Postmortem Neocortical (3)H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease
por: Pivtoraiko, Violetta N., et al.
Publicado: (2021)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome()
por: Neale, Natalie, et al.
Publicado: (2017)

Acute Regression in Down Syndrome
por: Handen, Benjamin, et al.
Publicado: (2021)

The importance of understanding individual differences in Down syndrome
por: Karmiloff-Smith, Annette, et al.
Publicado: (2016)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome
por: Dekker, Alain D., et al.
Publicado: (2018)

Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society
por: Hamlett, Eric D., et al.
Publicado: (2023)

Variation in the X-Linked EFHC2 Gene Is Associated with Social Cognitive Abilities in Males
por: Startin, Carla M., et al.
Publicado: (2015)

Brain amyloid and the transition to dementia in Down syndrome
por: Keator, David B., et al.
Publicado: (2020)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v7f3nreigab4vnl9cfr6vlvgem